Illumina Ventures is a corporate venture capital company in California that aims to improve human health by unlocking the power of the genome. Founded 2016 in Foster City, California, United States by Nicholas J. Naclerio, this venture capital firm invests in early stage companies. Its portfolio companies include Stilla Technologies, Ribometrix, Cradle Genomics, Encoded Therapeutics, Inc., DNA Script, LunaDNA, Kallyope, and SQZ Biotech. As of February 2020, Illumina Ventures has made 24 investments. Their most recent investment was on Feb 11, 2020, when Stilla Technologies raised €20M. Illumina Ventures has had two exits, the most notable of which include Human Longevity and Twist Bioscience. The company has raised 2 funds, their latest being Fund I. This fund was announced on Oct 16, 2017 and raised a total of $230M. The company focuses on applications of genomics in life science research, healthcare, agriculture and environmental science, public safety and personal wellness.